 The study found that there is a lack of consensus among U.S. dermatologists on how to define and treat moderate plaque psoriasis, which may lead to undertreatment and unsatisfactory clinical outcomes for patients with this condition. This article was authored by Melissa L. F. Knuckles, Eugenia Levi and Jennifer Saung.